de Morgan Stanley Encompass Health EHC Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 116 M | Comprar |
1,146,873
+249,891
| +28% | +USD 25.9 M | 0.01% | 1441 |
|
|
2026
Q1 | USD 86.8 M | Vender |
896,982
-22,046
| -2% | -USD 2.26 M | 0.01% | 1568 |
|
|
2025
Q4 | USD 97.5 M | Comprar |
919,028
+130,818
| +17% | +USD 15.2 M | 0.01% | 1471 |
|
|
2025
Q3 | USD 100 M | Comprar |
788,210
+17,241
| +2% | +USD 2.05 M | 0.01% | 1407 |
|
|
2025
Q2 | USD 94.5 M | Comprar |
770,969
+34,339
| +5% | +USD 3.92 M | 0.01% | 1369 |
|
|
2025
Q1 | USD 74.6 M | Vender |
736,630
-10,304
| -1% | -USD 1.01 M | 0.01% | 1470 |
|
|
2024
Q4 | USD 69 M | Comprar |
746,934
+18,995
| +3% | +USD 1.86 M | ﹤0.01% | 1545 |
|
|
2024
Q3 | USD 70.3 M | Comprar |
727,939
+9,074
| +1% | +USD 815 k | 0.01% | 1527 |
|
|
2024
Q2 | USD 61.7 M | Comprar |
718,865
+41,572
| +6% | +USD 3.49 M | ﹤0.01% | 1557 |
|
|
2024
Q1 | USD 55.9 M | Comprar |
677,293
+65,554
| +11% | +USD 4.8 M | ﹤0.01% | 1655 |
|
|
2023
Q4 | USD 40.8 M | Vender |
611,739
-6,450
| -1% | -USD 418 k | ﹤0.01% | 1943 |
|
|
2023
Q3 | USD 41.5 M | Vender |
618,189
-25,451
| -4% | -USD 1.75 M | ﹤0.01% | 1755 |
|
|
2023
Q2 | USD 43.6 M | Vender |
643,640
-108,199
| -14% | -USD 6.78 M | ﹤0.01% | 1693 |
|
|
2023
Q1 | USD 40.7 M | Comprar |
751,839
+79,717
| +12% | +USD 4.64 M | ﹤0.01% | 1738 |
|
|
2022
Q4 | USD 40.2 M | Vender |
672,122
-86,945
| -11% | -USD 4.73 M | ﹤0.01% | 1683 |
|
|
2022
Q3 | USD 34.3 M | Vender |
759,067
-298,869
| -28% | -USD 15 M | ﹤0.01% | 1632 |
|
|
2022
Q2 | USD 47.2 M | Comprar |
1,057,936
+113,087
| +12% | +USD 5.8 M | 0.01% | 1412 |
|
|
2022
Q1 | USD 53.5 M | Vender |
944,849
-198,233
| -17% | -USD 10.3 M | 0.01% | 1261 |
|
|
2021
Q4 | USD 59.3 M | Comprar |
1,143,082
+4,995
| +0.4% | +USD 258 k | 0.01% | 1219 |
|
|
2021
Q3 | USD 67.9 M | Comprar |
1,138,087
+295,766
| +35% | +USD 18.6 M | 0.01% | 1089 |
|
|
2021
Q2 | USD 52.3 M | Comprar |
842,321
+181,590
| +27% | +USD 12.1 M | 0.01% | 1277 |
|
|
2021
Q1 | USD 43 M | Comprar |
660,731
+403,270
| +157% | +USD 26.3 M | 0.01% | 1280 |
|
|
2020
Q4 | USD 16.9 M | Comprar |
257,461
+186,889
| +265% | +USD 11 M | ﹤0.01% | 1961 |
|
|
2020
Q3 | USD 3.65 M | Comprar |
70,572
+2,500
| +4% | +USD 128 k | ﹤0.01% | 3024 |
|
|
2020
Q2 | USD 3.35 M | Vender |
68,072
-93
| -0.1% | -USD 5.02 k | ﹤0.01% | 3078 |
|
|
2020
Q1 | USD 3.47 M | Vender |
68,165
-281,498
| -81% | -USD 16.2 M | ﹤0.01% | 2812 |
|
|
2019
Q4 | USD 19.3 M | Comprar |
349,663
+292,341
| +510% | +USD 15.9 M | ﹤0.01% | 1691 |
|
|
2019
Q3 | USD 2.88 M | Vender |
57,322
-14,831
| -21% | -USD 745 k | ﹤0.01% | 3460 |
|
|
2019
Q2 | USD 3.64 M | Vender |
72,153
-470,581
| -87% | -USD 22.8 M | ﹤0.01% | 3252 |
|
|
2019
Q1 | USD 25.2 M | Vender |
542,734
-85,874
| -14% | -USD 4.35 M | 0.01% | 1284 |
|
|
2018
Q4 | USD 30.9 M | Vender |
628,608
-173,368
| -22% | -USD 9.9 M | 0.01% | 1109 |
|
|
2018
Q3 | USD 49.7 M | Comprar |
801,976
+164,325
| +26% | +USD 10 M | 0.01% | 969 |
|
|
2018
Q2 | USD 34.4 M | Vender |
637,651
-19,188
| -3% | -USD 959 k | 0.01% | 1151 |
|
|
2018
Q1 | USD 29.9 M | Comprar |
656,839
+120,442
| +22% | +USD 5.16 M | 0.01% | 1301 |
|
|
2017
Q4 | USD 21.1 M | Comprar |
536,397
+46,780
| +10% | +USD 1.78 M | 0.01% | 1615 |
|
|
2017
Q3 | USD 18.1 M | Comprar |
489,617
+179,574
| +58% | +USD 6.4 M | 0.01% | 1682 |
|
|
2017
Q2 | USD 11.9 M | Vender |
310,043
-158,154
| -34% | -USD 5.79 M | ﹤0.01% | 2004 |
|
|
2017
Q1 | USD 15.9 M | Vender |
468,197
-91,467
| -16% | -USD 3 M | ﹤0.01% | 1759 |
|
|
2016
Q4 | USD 18.4 M | Comprar |
559,664
+66,127
| +13% | +USD 2.15 M | 0.01% | 1622 |
|
|
2016
Q3 | USD 15.9 M | Comprar |
493,537
+155,031
| +46% | +USD 5.02 M | 0.01% | 1627 |
|
|
2016
Q2 | USD 10.5 M | Comprar |
338,506
+27,466
| +9% | +USD 859 k | ﹤0.01% | 1947 |
|
|
2016
Q1 | USD 9.31 M | Comprar |
311,040
+126,731
| +69% | +USD 3.5 M | ﹤0.01% | 1916 |
|
|
2015
Q4 | USD 5.1 M | Comprar |
184,309
+133,774
| +265% | +USD 3.81 M | ﹤0.01% | 2644 |
|
|
2015
Q3 | USD 1.54 M | Vender |
50,535
-4,705
| -9% | -USD 164 k | ﹤0.01% | 3744 |
|
|
2015
Q2 | USD 2.02 M | Vender |
55,240
-164,252
| -75% | -USD 5.86 M | ﹤0.01% | 3615 |
|
|
2015
Q1 | USD 7.75 M | Vender |
219,492
-585,212
| -73% | -USD 20 M | ﹤0.01% | 2327 |
|
|
2014
Q4 | USD 24.6 M | Vender |
804,704
-27,513
| -3% | -USD 858 k | 0.01% | 1307 |
|
|
2014
Q3 | USD 24.4 M | Comprar |
832,217
+295,621
| +55% | +USD 9.01 M | 0.01% | 1278 |
|
|
2014
Q2 | USD 15.3 M | Comprar |
536,596
+457,049
| +575% | +USD 12.7 M | 0.01% | 1656 |
|
|
2014
Q1 | USD 2.27 M | Vender |
79,547
-750,614
| -90% | -USD 19.5 M | ﹤0.01% | 3305 |
|
|
2013
Q4 | USD 22 M | Comprar |
830,161
+667,841
| +411% | +USD 18.6 M | 0.01% | 1273 |
|
|
2013
Q3 | USD 4.45 M | Comprar |
162,320
+18,993
| +13% | +USD 488 k | ﹤0.01% | 2541 |
|
|
2013
Q2 | USD 3.28 M | Comprar |
+143,327
| Nuevas | +USD 3.24 M | ﹤0.01% | 2721 |
|
Otros fondos que tienen EHC en su cartera
Posición de Morgan Stanley en EHC: resumen de T2 2026
Morgan Stanley aumentó su participación en Encompass Health (EHC) en 28% durante T2 2026, al comprar aproximadamente USD 25.9 M y elevar la posición a 1,146,873 acciones con un valor de USD 116 M. La posición representa 0.01% de la cartera y ocupa el puesto #1441.
Morgan Stanley reportó por primera vez una posición en EHC en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 599 fondos que sigue Wall St. Rank mantienen una posición en EHC.
- Al cierre de T2 2026, Morgan Stanley tenía 1,146,873 acciones de Encompass Health con un valor de USD 116 M.
- Morgan Stanley compró 249,891 acciones de Encompass Health en T2 2026, por un monto estimado de USD 25.9 M.
- Encompass Health representó 0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 1441.
- Morgan Stanley reportó por primera vez una posición en Encompass Health en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 599 fondos que sigue Wall St. Rank tenían Encompass Health en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.